As artificial intelligence (AI) continues to make significant advances, the leaders of clinical trials should not underestimate its capabilities for improving patient recruitment, retention, and ...

Drugs are man-made miracles. They enhance our health, cure diseases, and extend our lives. However, drug development is not easy. It is a remarkably long, expensive, and complex process. On average, ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...

The conversation took place during the Veeva R&D Summit in Boston. At the Veeva R&D and Quality Summit in Boston, Pharmaceutical Executive spoke with three industry leaders who discussed their ...

The clinical development plan is a blueprint that brings a new drug discovery from preclinical development to market approval. It helps to regulate the process of drug discovery, ensuring patient ...

Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and expectations from regulators, payers, and patients continue to rise. Meanwhile, ...

Addressing the complexity of FSP and FSO outsourcing models, this new solution, powered by Science Exchange's supplier orchestration platform, modernizes clinical supplier collaboration and budget ...

Werewolf Therapeutics provided a business update highlighting key milestones for 2025 regarding its clinical development programs. The company is expecting to release data from the Phase 1/1b clinical ...

The clinical trial supply and logistics market is set for significant growth due to rising drug research investments and ...